Quarter Period Consolidated Statement Of Comprehensive Income

Takeda Pharmaceutical Company Limited - Filing #7251660

Concept 2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
Quarter period consolidated statement of comprehensive income
Statement of comprehensive income
Profit (loss)
JPY
JPY
152,820,000,000 JPY
152,820,000,000 JPY
152,820,000,000 JPY
152,820,000,000 JPY
JPY
338,874,000,000 JPY
JPY
338,874,000,000 JPY
338,874,000,000 JPY
338,874,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.